Zhengye Biotechnology Holding Limited (ZYBT)Healthcare | Drug Manufacturers - Specialty & Generic | Jilin, China | NasdaqCM
0.71 USD
-0.07
(-9.590%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.69 -0.01 (-0.014%) ⇩ (July 13, 2026, 7:38 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:41 a.m. EDT
The immediate outlook is severely clouded by a brutal recent price collapse, with the stock tumbling nearly 45% from its July highs back to current lows, signaling intense selling pressure and a broken technical structure. While the company boasts a unique moat with exclusive drug approvals and a pivot to pet vaccines, the financial reality is stark: revenue has contracted by over 40%, operating margins are deeply negative at -77%, and the business is burning cash with no path to profitability visible in the trailing twelve months. The balance sheet is fragile, carrying debt that exceeds its cash reserves, and the dual-class share structure introduces governance risks that further dampen investor appeal. With no dividend history to speak of and a market that has already punished the stock heavily, there is no safe entry point for a short-term trader, and the fundamental deterioration makes a long-term hold highly perilous at these valuations. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.105266 |
| AutoARIMA | 0.105299 |
| MSTL | 0.106356 |
| AutoTheta | 0.168127 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 13.89 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.311 |
| Excess Kurtosis | -0.33 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 24.48 |
| Revenue per Share | 2.455 |
| Market Cap | 33,420,400 |
| Profit Margins | -59.97% |
| Website | https://www.jlzybio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.867121 |
| Address1 | No.1 Lianmeng Road |
| Address2 | Jilin Economic & Technical Development Zone |
| All Time High | 14.3 |
| All Time Low | 0.616 |
| Ask | 0.9458 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 100,320 |
| Average Daily Volume3 Month | 102,865 |
| Average Volume | 102,865 |
| Average Volume10Days | 100,320 |
| Bid | 0.5111 |
| Bid Size | 2 |
| Book Value | 0.91483665 |
| City | Jilin |
| Country | China |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.7052 |
| Current Ratio | 1.141 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.82 |
| Day Low | 0.7052 |
| Debt To Equity | 24.48 |
| Display Name | Zhengye Biotechnology Holding |
| Ebitda | -44,623,000 |
| Ebitda Margins | -0.38347998 |
| Enterprise To Ebitda | -2.622 |
| Enterprise To Revenue | 1.006 |
| Enterprise Value | 117,023,272 |
| Eps Trailing Twelve Months | -0.22 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.84088 |
| Fifty Day Average Change | -0.13567996 |
| Fifty Day Average Change Percent | -0.16135474 |
| Fifty Two Week Change Percent | -86.7121 |
| Fifty Two Week High | 13.08 |
| Fifty Two Week High Change | -12.3748 |
| Fifty Two Week High Change Percent | -0.94608563 |
| Fifty Two Week Low | 0.616 |
| Fifty Two Week Low Change | 0.08920002 |
| Fifty Two Week Low Change Percent | 0.14480522 |
| Fifty Two Week Range | 0.616 - 13.08 |
| Financial Currency | CNY |
| First Trade Date Milliseconds | 1,736,260,200,000 |
| Float Shares | 6,261,823 |
| Free Cashflow | 39,576,752 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 269 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.20513001 |
| Gross Profits | 23,869,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16163999 |
| Held Percent Institutions | 0.011039999 |
| Implied Shares Outstanding | 47,391,377 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,025-01-07 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited. |
| Long Name | Zhengye Biotechnology Holding Limited |
| Market | us_market |
| Market Cap | 33,420,400 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1858707878 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -69,784,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 36,965,273 |
| Open | 0.82 |
| Operating Cashflow | 13,333,000 |
| Operating Margins | -0.77039003 |
| Payout Ratio | 0.0 |
| Phone | 86 432 6304 7008 |
| Post Market Change | -0.013900042 |
| Post Market Change Percent | -1.9710779 |
| Post Market Price | 0.6913 |
| Post Market Time | 1,783,985,891 |
| Previous Close | 0.78 |
| Price Hint | 4 |
| Price To Book | 0.77084804 |
| Price To Sales Trailing12 Months | 0.2872106 |
| Profit Margins | -0.59971 |
| Quick Ratio | 0.584 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.074799955 |
| Regular Market Change Percent | -9.589739 |
| Regular Market Day High | 0.82 |
| Regular Market Day Low | 0.7052 |
| Regular Market Day Range | 0.7052 - 0.82 |
| Regular Market Open | 0.82 |
| Regular Market Previous Close | 0.78 |
| Regular Market Price | 0.7052 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 7,422 |
| Return On Assets | -0.094790004 |
| Return On Equity | -0.2517 |
| Revenue Growth | -0.409 |
| Revenue Per Share | 2.455 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 47,391,376 |
| Shares Percent Shares Out | 0.00090000004 |
| Shares Short | 43,518 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 29,643 |
| Short Name | Zhengye Biotechnology Holding L |
| Short Percent Of Float | 0.001 |
| Short Ratio | 0.24 |
| Source Interval | 15 |
| Symbol | ZYBT |
| Total Cash | 51,892,000 |
| Total Cash Per Share | 1.095 |
| Total Debt | 75,083,000 |
| Total Revenue | 116,362,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.40534 |
| Two Hundred Day Average Change | -0.70013994 |
| Two Hundred Day Average Change Percent | -0.4981997 |
| Type Disp | Equity |
| Volume | 7,422 |
| Website | https://www.jlzybio.com |